Provided by Tiger Fintech (Singapore) Pte. Ltd.

Meiragtx Holdings Plc

6.61
-0.0600-0.90%
Post-market: 6.610.00000.00%17:59 EDT
Volume:942.17K
Turnover:6.25M
Market Cap:531.22M
PE:-2.91
High:6.80
Open:6.67
Low:6.54
Close:6.67
Loading ...

MeiraGTx Holdings - Receives UK Regulatory Approvals for Proposed Transactions With Hologen, Expected to Close in July 2025 - SEC Filing

THOMSON REUTERS
·
26 Jun

MeiraGTx Holdings plc Receives UK Regulatory Approvals for Proposed Transactions with Hologen Limited, Expected to Close in July 2025

Reuters
·
26 Jun

MeiraGTx Holdings plc Conducted Annual Shareholders Meeting

Reuters
·
17 Jun

Meiragtx Holdings (MGTX) Receives a New Rating from Lucid Capital

TIPRANKS
·
10 Jun

Chardan Adjusts MeiraGTx Price Target to $35 From $38, Maintains Buy Rating

MT Newswires Live
·
14 May

MeiraGTx Holdings Is Maintained at Buy by Chardan Capital

Dow Jones
·
14 May

ADVISORY-Dated alert on MeiraGTx collaboration with Hologen AI withdrawn

Reuters
·
13 May

MeiraGTx Hldgs Q1 EPS $(0.51) Misses $(0.45) Estimate, Sales $1.93M Miss $4.43M Estimate

Benzinga
·
13 May

MeiraGTx Holdings PLC reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
13 May

MeiraGTx Holdings Plc - Announces $200 Million Strategic Collaboration With Hologen AI - SEC Filing

THOMSON REUTERS
·
13 May

MeiraGTx Holdings plc Reports Q1 2025 Results: Decrease in Interest Expense and Gain on Foreign Currency, No Gain on Sale of Nonfinancial Assets

Reuters
·
13 May

BRIEF-MeiraGTx Q1 EPS USD -0.51

Reuters
·
13 May

MeiraGTx Q1 EPS USD -0.51

THOMSON REUTERS
·
13 May

Sector Update: Health Care Stocks Softer Friday Afternoon

MT Newswires Live
·
10 May

MeiraGTx Shares up 4% After Co Receives FDA's Regenerative Medicine Advanced Therapy Designation for Parkinson’s Disease Treatment

THOMSON REUTERS
·
09 May

MeiraGTx Shares Jump 11.5% Premarket After Co Receives FDA's Regenerative Medicine Advanced Therapy Designation for Parkinson’s Disease Treatment

THOMSON REUTERS
·
09 May

MeiraGTx Says FDA Granted RMAT Designation to AAV-GAD for Treating Parkinson's; Shares Up Pre-Bell

MT Newswires Live
·
09 May

MeiraGTx- Granted FDA Regenerative Medicine Advanced Therapy Designation for Aav-Gad for Treatment of Parkinson’s Disease

THOMSON REUTERS
·
09 May

MeiraGTx Holdings PLC expected to post a loss of 49 cents a share - Earnings Preview

Reuters
·
05 May

Top Premarket Decliners

MT Newswires Live
·
28 Apr